Target intelligence / Profile preview

Non-STAT5A mRNAs with seed-region complementarity

Molecular classification
Messenger RNA (mRNA), Off-target transcripts
01

Overview

Non-STAT5A mRNAs with seed-region complementarity refers to the collection of messenger RNA transcripts that are unintentionally downregulated by RNA interference (RNAi) tools, such as siRNAs or shRNAs, designed to target the STAT5A gene. This phenomenon occurs because the 'seed region' of the small RNA guide strand (typically nucleotides 2-8) can recognize and bind to partially complementary sequences in the 3' untranslated regions (UTRs) of many other genes, mimicking the natural regulatory mechanism of microRNAs (Birmingham et al., 2006; Jackson et al., 2003). In the case of STAT5A, a transcription factor critical for hematopoietic signaling and oncogenesis, such off-target effects can lead to significant cellular toxicity or misleading phenotypic observations in research and clinical development. STAT5A itself is a member of the Signal Transducer and Activator of Transcription family and plays a pivotal role in cytokine signaling, cell growth, and survival. Dysregulation of STAT5A is associated with various leukemias and solid tumors, making it an attractive therapeutic target; however, the development of RNAi-based inhibitors is complicated by these potential seed-region mediated off-target effects. Consequently, researchers focus on identifying and mitigating these 'Non-STAT5A' interactions using chemical modifications or advanced bioinformatics to ensure that the therapeutic effect is solely due to the inhibition of the intended STAT5A protein.

Other names
STAT5A siRNA off-targetsSeed-matched off-target transcriptsmiRNA-like off-targets of STAT5A RNAi
02

Mechanism of action

Unintended gene silencing via a microRNA-like mechanism where the seed region (nucleotides 2-7 or 2-8) of a STAT5A-targeting siRNA or shRNA binds to complementary sequences in the 3' untranslated regions (UTRs) of non-target mRNAs, leading to their degradation or translational repression.

03

Biological functions

Protein synthesisGene expression regulation
04

Disease associations

Off-target toxicityUnintended phenotypic effects
05

Safety considerations

Off-target gene silencingCytotoxicityConfounding experimental resultsUnintended phenotypic changes
06

Interacting drugs

Experimental STAT5A-targeting siRNAs

1 more in the full profile.

07

Biomarkers

Transcriptome profilingRNA-seqGene expression signatures

Beyond the preview

Go deeper on Non-STAT5A mRNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-STAT5A mRNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call